SEC FORM 4
$4,403.52
Aquestive Therapeutics, Inc. (AQST)
Acquisition (code X) of 4,587 shares at $0.96 per share.
Reporting Person Jung Cassie · Officer Title Chief Operating Officer · Transaction Code X
Traded Sep 3, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001214659-26-011475 · filed 2026-09-08 · View filing →